AI assistant
Convatec Group PLC Director's Dealing 2022
4959_dirs_2022-03-25_9cf3f878-c376-403d-b340-1ad147c65ea6.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 1077G
ConvaTec Group PLC
25 March 2022
25 March 2022
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 22 March 2022, Sharon O'Keefe, Non-Executive Director and PDMR, purchased 3,200 Shares, held as American Depositary Receipts (ADRs). Each ADR represents four ordinary shares of 10 pence in the Company. Sharon O'Keefe's resulting shareholding is 3,200 Shares.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Sharon O'Keefe | ||
| 2 | Reason for the notification | |||
| a) | Position/Status | Non-Executive Director | ||
| b) | Initial notification/Amendment | Initial notification | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | ConvaTec Group Plc | ||
| b) | LEI | 213800LS272L4FIDOH92 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in ConvaTec Group Plc GB00BD3VFW73 |
||
| b) | Nature of the transaction | American Depositary Receipts (ADRs), each representing four ordinary shares of 10p each in ConvaTec Group Plc | ||
| c) | Price(s) and volume(s) | Price(s) $11.50 |
Volume(s) 800 |
|
| d) | Aggregated information - Aggregated volume - Price |
800 $9,200 |
||
| e) | Date of the transaction | 2022-03-22 | ||
| f) | Place of the transaction | New York Stock Exchange (NYSE) | ||
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, ConvaTec +44 (0)782 644 7807
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFEVVSIEFIF